• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Fueling Cognitive Health through Nutrition & Supplementation

    2020 State of the Industry: High Expectations

    2020 International Buyers' Guide

    Clean Label Questions: Anything But ‘Short and Sweet’

    Key Trends in Functional Foods & Beverages for 2020
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Live From Shows
    Top News
    Pharmactive Affron Saffron May Help Relieve Depression Symptoms

    Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice

    Kaneka Extends Deadline for Innovation Contest

    Maternal 5-MTHF Levels Predict Fetal Folate Status

    GOED Publishes 2017-2018 Omega-3 Raw Materials Report
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Pharmactive Affron Saffron May Help Relieve Depression Symptoms

    Kaneka Extends Deadline for Innovation Contest

    Maternal 5-MTHF Levels Predict Fetal Folate Status

    GOED Publishes 2017-2018 Omega-3 Raw Materials Report

    Probiotic Strain Shown to Reduce Symptoms of Infant Colic
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Pharmactive Affron Saffron May Help Relieve Depression Symptoms

    Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice

    Maternal 5-MTHF Levels Predict Fetal Folate Status

    GOED Publishes 2017-2018 Omega-3 Raw Materials Report

    Obesity and Gum Disease May Have Common Connection: Inflammation
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Pharmactive Affron Saffron May Help Relieve Depression Symptoms

    Maternal 5-MTHF Levels Predict Fetal Folate Status

    Obesity and Gum Disease May Have Common Connection: Inflammation

    Probiotic Strain Shown to Reduce Symptoms of Infant Colic

    Clinical Trial Confirms Joint Health Benefits of NEM Brand Eggshell Membrane in 7 Days
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    BatchMaster Software, Inc.

    MitoCarn (Alfasigma)

    Sabinsa Corporation

    Aiya America (Matcha by Aiya)

    PLT Health Solutions
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    MitoCarn (Alfasigma)

    PLT Health Solutions

    ExcelVite Sdn. Bhd.

    Bioenergy Life Science, Inc. (BLS)

    Aiya America (Matcha by Aiya)
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    AMR101 Takes on Lovaza

    Amarin enters final phase of testing for its promising fish oil medication for high cholesterol.

    Related CONTENT
    • GSK Acquires U.K.’s Top Sports Nutrition Company
    • Epanova Phase III Trial Begins
    • FDA Accepts NDA Filing for Amarin
    • FDA Accepts NDA Filing for Amarin
    • Growth Opportunities in Sports Nutrition
    Joanna Cosgrove11.08.10
    For patients with hypertriglyceridemia—a dangerous condition characterized by a triglyceride level over 500 mg/dL—a popular and effective therapy of late has been the fish oil-based pharmaceutical Lovaza from GlaxoSmithKline (GSK)*, coupled with statin therapy. But a new, more specialized fish oil medication from Amarin Corp., of Dublin, Ireland, recently entered Phase III clinical trials and is poised to siphon valuable market share from Lovaza.
     
    Dubbed AMR101, the product is an ultra pure (>96%) ethyl ester of eicosapentaenoic acid (ethyl-EPA), a long chain highly unsaturated fatty acid in the omega 3 class. Amarin believes the product to have a beneficial impact on such biological factors as anti-inflammatory mechanisms, cell membrane composition and plasticity and regulation of glucose metabolism, though its impact on triglyceride levels is an area buoyed by the most clinical promise.
     
    In an interview with Nutraceuticals World, Declan Doogan, MD, Amarin’s chief medical officer, talked about three key points of difference that will likely pit AMR101 squarely against GSK’s Lovaza.
     
    For starters, AMR101 is pure EPA and doesn’t contain any DHA. Amarin is confident that the absence of DHA confers distinct advantages in the quest to lower high triglycerides. “DHA is associated with elevations in LDL cholesterol. Because AMR101 doesn’t have DHA, we believe we will be without the LDL signal to the same extent as Lovaza,” he explained. “What’s important to understand is that Lovaza, when given with a statin is still associated with an elevation of LDL so therefore in many cases you would still have to adjust the dose of the statin. AMR101 is cleaner in that when you combine AMR101 and a statin, you should not get this LDL change. We believe it will be an easier drug for doctors to prescribe than Lovaza.”
     
    In addition to cutting out the DHA effect, AMR101 has also demonstrated its efficacy in half the dose of Lovaza. “The dose of Lovaza is four grams (or four capsules) per day for patients with very high triglycerides of 500 or above,” Dr. Doogan said. “With AMR101 the dose is likely to be two grams or two capsules for the same population, which is still to be proven in our clinical trials but that’s the plan.”
     
    The third differentiation relates to the medication’s lack of a fishy aftertaste, which Dr. Doogan attributed to the nonexistence of DHA in the formulation.
     
    “The question may be asked ‘Yes, but what do you lose by taking DHA out of AMR101 or fish oil?’ I don’t believe you lose anything,” he said. “If you’re using this drug as a treatment for vascular disease and cardiovascular complications, we have data to show in 19,000 patients if you add AMR101 or 96% EPA to a statin, compared with a statin alone you will get an additional 19% reduction in coronary events. You turbo-charge the statin when you give AMR101. That’s saying that pure EPA alone will do the business.”
     
    He also added that although DHA is excluded from AMR101 it doesn’t mean DHA doesn’t have a place in the nutraceutical landscape. “DHA is an integral component of nutritional supplements and food preparations for children, such as baby formulas,” he said. “It’s very important for the maturing brain and retinas. But that’s a very different proposition than managing adult cardiovascular events.”
     
    He additionally acknowledged the benefits of nutraceutical grade omega 3. “I understand the value of nutraceutical supplementation of omeg -3 as well as the nutraceutical market for omega 3. As a physician, I would recommend omega 3 as a wellness product,” he said. “But when somebody comes to the doctor with substantially elevated triglycerides (500+) I would strongly believe that the doctor would want to prescribe a well-tried and tested formulation and dose of omega 3 and that’s the reason for the likes of Lovaza and AMR101.”  
     
    Mounting Research
     
    Amarin’s AMR101 EPA formulation is not entirely unique, as pure EPA has been available in Japan (marketed by Mochida as Epadel) for a decade and has been extensively researched. In fact, according to Amarin, a study called JELIS demonstrated that EPA plus statins reduced coronary events in at-risk patients by about 19% compared to statins alone. Based on this evidence, there is quiet confidence that the two current Phase 3 AMR101 trials will be successful.
     
    The first trial, called Marine, is set to examine about 250 of the same patients targeted by Lovaza—those, for example, who have triglyceride levels above 500 mg/dL.
     
    The second trial, called Anchor, will look at patients with triglyceride levels above 250mg/dL and below 500 mg/dL, who also are receiving statin therapy for high LDL cholesterol. This group has what is referred to as mixed dyslipidemia. According to Amarin, this trial aims to extend the prescription label for AMR101 to a population that Lovaza is not approved to treat.
     
    There are approximately 10 times more patients in this group than the population Marine/Lovaza targets. This trial is expected to complete recruitment of approximately 650 patients in early 201.
     
    “We have masses of data on the drug to show that it’s safe and to show our confidence in the drug’s effect on triglycerides and also cardiovascular disease,” Dr. Doogan concluded.
     
    Results for the Marine trial are expected in early 2011, with Anchor trial results to follow. Dr. Doogan said he expected an application to the FDA to be filed shortly thereafter. 
     
     
    *When contacted, GSK declined the opportunity to make a statement, citing company policy not to comment on products that are not yet at market.
    Related Searches
    • Japan
    • Omega-3
    • EPA
    • Children
    Related Knowledge Center
    • Cardiovascular Health
    • Research
    Suggested For You
    Qualitas Health Enters Production Partnership Qualitas Health Enters Production Partnership
    AHPA Encourages EPA to Reform Pesticide Regulations AHPA Encourages EPA to Reform Pesticide Regulations
    Nature Made Introduces Four New Supplements Nature Made Introduces Four New Supplements
    Coromega to Showcase Coromega Max and Women’s Health Omega-3 Supplements Coromega to Showcase Coromega Max and Women’s Health Omega-3 Supplements
    Coalition Forms to Fight Food Waste Coalition Forms to Fight Food Waste
    NARB Recommends Novartis/GSK Discontinue Benefiber Claim: ‘Helps Maintain Regularity’ NARB Recommends Novartis/GSK Discontinue Benefiber Claim: ‘Helps Maintain Regularity’
    Weight Loss & Sexual Enhancement Products Recalled Weight Loss & Sexual Enhancement Products Recalled
    GlaxoSmithKline Recalls Alli GlaxoSmithKline Recalls Alli
    Amarin Receives $100 Million in Financing Amarin Receives $100 Million in Financing
    Amarin Announces FDA Approval of Vascepa for the Reduction of Triglyceride Levels Amarin Announces FDA Approval of Vascepa for the Reduction of Triglyceride Levels
    Growth Opportunities in Sports Nutrition Growth Opportunities in Sports Nutrition
    FDA Accepts NDA Filing for Amarin FDA Accepts NDA Filing for Amarin
    FDA Accepts NDA Filing for Amarin FDA Accepts NDA Filing for Amarin
    Epanova Phase III Trial Begins Epanova Phase III Trial Begins
    GSK Acquires U.K.’s Top Sports Nutrition Company GSK Acquires U.K.’s Top Sports Nutrition Company

    Related Online Exclusives

    • Bone & Joint Health | Healthy Aging | Proteins, Peptides, Amino Acids | Research | Skin Health | Sports Nutrition | Women's Health
      Collagen May Help Address Noticeable Signs of Aging

      Collagen May Help Address Noticeable Signs of Aging

      Market research indicates continued growth for bone/joint health, skin/beauty, and sports nutrition products.
      By Nutraceuticals World Staff 09.26.19

    • Cognitive Function | Herbs & Botanicals | Research
      Regular Tea Consumption May Protect Brain Health

      Regular Tea Consumption May Protect Brain Health

      Subjects who drank green, oolong, or black tea at least four times a week for about 25 years had more efficiently interconnected brain regions.
      By Nutraceuticals World Staff 09.16.19

    • Cancer Risk | Herbs & Botanicals | Men's Health | Research
      Regular Consumption of Mushrooms May Help Prevent Prostate Cancer

      Regular Consumption of Mushrooms May Help Prevent Prostate Cancer

      Finding was especially relevant for Japanese men 50 and older.
      By Sean Moloughney, Editor 09.06.19


    • Cancer Risk | Cardiovascular Health | Diabetes & Blood Sugar Management | Digestive Health | Research | Sweeteners
      Sugary Soft Drinks Linked with Higher Death Risk

      Sugary Soft Drinks Linked with Higher Death Risk

      Researchers found higher all-cause mortality and cause-specific death risk among a European study cohort.
      By Sean Moloughney, Editor 09.06.19

    • Antioxidants | Cardiovascular Health | Cognitive Function | Diabetes & Blood Sugar Management | Research
      Resveratrol: The Healthy Aging Nutrient

      Resveratrol: The Healthy Aging Nutrient

      Market projected to see continued growth as product development accelerates.
      08.22.19

    • Research | Skin Health | Vitamins
      Vitamin A May Decrease Risk of Common Skin Cancer

      Vitamin A May Decrease Risk of Common Skin Cancer

      Recent rise cutaneous squamous cell carcinoma due to longer life expectancy, more sun exposure, and lifestyle changes.
      08.11.19


    • Antioxidants | Cardiovascular Health | Dietary Supplements | Quality & Safety | Testing | Vitamins | World Markets
      CoQ10 Market Experiencing Healthy Growth

      CoQ10 Market Experiencing Healthy Growth

      Heart health benefits fuel expanding global industry.
      07.25.19

    • Cardiovascular Health | Minerals | Omega-3s | Research | Research News | Vitamins
      Omega-3s, Folic Acid, Salt Reduction Shown to Benefit Heart Health Outcomes

      Omega-3s, Folic Acid, Salt Reduction Shown to Benefit Heart Health Outcomes

      Combination of calcium and vitamin D might increase risk for stroke, according to review of clinical trials.
      07.17.19

    • Diabetes & Blood Sugar Management | Digestive Health | Fiber & Carbohydrates | Probiotics & Prebiotics | Research | Weight Management/Weight Loss
      Resistant Starch Research Roundup

      Resistant Starch Research Roundup

      A hot topic in research communities and in the dietary supplement world, here’s a rundown of recent studies on resistant starch.
      By Rhonda Witwer, Executive Director, Resistant Starch Research 05.29.19


    • Cognitive Function | Healthcare Trends | Infant & Children's Health | Research | Vitamins
      Choline: The Essential Nutrient Americans Still Aren’t Consuming Enough

      Choline: The Essential Nutrient Americans Still Aren’t Consuming Enough

      Deficiency can have serious health implications.
      03.28.19

    • Cancer Risk | Cardiovascular Health | Diabetes & Blood Sugar Management | Fiber & Carbohydrates | Research | Weight Management/Weight Loss
      High Intake of Dietary Fiber & Whole Grains May Reduce Risk of Non-Communicable Diseases

      High Intake of Dietary Fiber & Whole Grains May Reduce Risk of Non-Communicable Diseases

      Review offers compelling evidence that quality carbohydrates are major determinants of numerous health outcomes.
      01.28.19

    • Consumer Trends | Healthcare Trends | Herbs & Botanicals | Inflammation | Omega-3s | Regulations | Research | Vitamins | World Markets
      Top Podcasts of 2018

      Top Podcasts of 2018

      Take a listen to Nutraceuticals World’s most popular podcasts of 2018.
      12.31.18

    • Dietary Supplements | Digestive Health | Immune Function | Probiotics & Prebiotics | Quality & Safety | Research
      Harvard Researcher Questions Probiotic Benefits

      Harvard Researcher Questions Probiotic Benefits

      While a popular, fast-growing market, probiotics still have critics.
      By Sean Moloughney, Editor 09.26.18

    • Bone & Joint Health | Cognitive Function | Dietary Supplements | Herbs & Botanicals | Men's Health | Mood Health & Sleep | Research | Sports Nutrition
      Ashwagandha: Leading the Adaptogenic Revolution

      Ashwagandha: Leading the Adaptogenic Revolution

      With a broad range of traditional uses, this flagship botanical of Ayurveda has taken root in modern markets.
      By Sean Moloughney, Editor 05.31.18

    • Cardiovascular Health | Minerals | Research | Vitamins
      Scientific Review Claims No Heart Health Benefit for Common Dietary Supplements

      Scientific Review Claims No Heart Health Benefit for Common Dietary Supplements

      Authors noted folic acid and B vitamins shown to reduce stroke risk.
      05.29.18

    Breaking News
    • International Scientific Society Calls for Omega-3 Blood Testing in Future Research
    • Pharmactive Affron Saffron May Help Relieve Depression Symptoms
    • Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice
    • Kaneka Extends Deadline for Innovation Contest
    • Maternal 5-MTHF Levels Predict Fetal Folate Status
    View Breaking News >
    CURRENT ISSUE

    December 2019

    • 2020 International Buyers' Guide
    • 2020 State of the Industry: High Expectations
    • Fueling Cognitive Health through Nutrition & Supplementation
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    International Scientific Society Calls for Omega-3 Blood Testing in Future Research
    Pharmactive Affron Saffron May Help Relieve Depression Symptoms
    Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice
    Coatings World

    Latest Breaking News From Coatings World

    PPG Appoints Robert King as VP, Global Operations, Industrial Segment
    Greenkote PLC Reports Upsurge in Powder Coatings Applications on Brake Calipers
    Addipel Moves to New HQ, Expands Production Facility
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMR Surgical Taps New CEO
    Companies Partner to Develop Instrument-Free Molecular Diagnostic Tests
    BWXT to Produce Medical Radioisotope Germanium-68 to Meet Rise in Demand
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Antares Vision Introduces Raised Stopper Machine
    AbbVie, Scripps Collaborate on New Therapeutics
    Sanofi Pasteur Awarded HHS Pandemic Flu Vax Contract
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Firmenich Wants You To Smell & Taste the Pantone Color of the Year
    L'Oréal Paris - And Celebs - Celebrate 14th Annual Women of Worth
    Henkel's göt2b Partners with DJ Pauly D
    Happi

    Latest Breaking News From Happi

    Caribbean Natural Taps New Sales Rep.
    HCPA Responds to 1,4-Dioxane Bill
    MAC Introduces Lip Lacquer
    Ink World

    Latest Breaking News From Ink World

    ePac Flexible Packaging Expands into Asia Pacific Market
    Smurfit Kappa Announces Board Changes
    Haney, HP Developing Sustainable Fashion Packaging for Heron Preston
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Interket UK purchases third MPS flexo press
    Michael Ring named EVP of W+D North America
    Polykote announces new UV inkjet labelstock
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Fitesa Buys Freudenberg's South American Hygiene Business
    Fameccanica Partners with Aeroflex
    Nice-Pak to Offer Sustainable Solutions to Every Customer
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    InVivo Therapeutics Attains 25 Percent Enrollment in Spinal Cord Injury Study
    BioPrax Biofilm Disruption Device Granted FDA Breakthrough Device Designation
    Orthofix Appoints New Spine Business Leader
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Osram’s Managing Board Invites ams to Talks About Future
    Yole: Emerging Printing Fills Gap for Rising Electronics Applications
    European Industries Lead New Graphene Flagship Projects to Shape EU’s Environmental Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.